LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Spine/Zyga Technology: Positive Results for SImmetry
Spine

Zyga Technology: Positive Results for SImmetry

November 8, 2016 2 min read Premium comments

Advertisement

Zyga Technology: Positive Results for SImmetry
Slmmetry Sacroiliac (SI) Joint Fusion / Courtesy of Zyga Technology, Inc.
Secondary

Zyga Technology, Inc. has released 12-month fusion and clinical results for patients receiving Slmmetry Sacroiliac (SI) Joint Fusion with decortication. The results of the prospective, multicenter study were recently presented at the 2016 Society for Minimally Invasive Spine Surgery (SMISS) Annual Meeting by William Cross, M.D., an orthopedic trauma surgeon at the Mayo Clinic in Rochester, Minnesota.

“Minimally Invasive SI joint fusion has been established as an effective treatment for certain patients suffering from SI joint disorders, but many technologies available today don’t follow the accepted orthopedic principles that lead to successful long-term fusion, ” said Dr. Cross, the lead author and presenter at the SMISS scientific meeting, in the October 17, 2016 news release. “For me, it’s common sense that SI joint fusion should include decortication and bone grafting to achieve long-term success. The results of this study provide compelling evidence that decortication and bone grafting may contribute to earlier fusion, and that the procedure provides significant pain relief at one year post-op.”

According to the news release, “…19 patients at three institutions underwent a CT scan 12 and 24 months after receiving minimally invasive SI joint fusion with decortication and bone grafting. CT images were reviewed by a non-biased, independent radiology core laboratory to assess fusion in relation to the joint and the area of decortication. At 12 months, fusion was reported in 74% of patients, and back pain decreased from 7.9 to 2.2 (72%). Of patients in whom fusion was reported, 86% showed fusion in the area of decortication. Freedom from device- or procedure-related adverse events through 12 months was 100%. 24-month results for the study are expected in early 2017.”

Dr. Cross told OTW, “One of the most interesting findings in this study is the durable nature of pain relief in the vast majority of patients at one year. Sustained improvements of over five points in the Numerical Pain score at one year is outstanding. It is clear that our beliefs in the fundamentals of joint arthrodesis (joint decortication, bone grafting, and stabilization) are sound and provide most patients with considerable and durable pain relief.”

“Most orthopedic surgeons should recognize that when principles of arthrodesis are followed, predictable fusion and pain relief can be anticipated in appropriately selected patients. Our data really speaks for itself and provides clear evidence on the merits of joint decortication and bone grafting.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy